The Rize Cybersecurity and Data Privacy UCITS ETF (CYBR) and the Rize Medical Cannabis and Life Sciences UCITS ETF (FLWR) are listed on the London Stock Exchange and the Frankfurt Stock Exchange.
CYBR and FLWR can be passported into the Netherlands, Denmark, Sweden and Finland as a result of the expansion.
The firm launched the two products in February 2020. CYBR and FLWR have a total expense ratio (TER) of 0.45% and 0.65%, respectively.
CYBR offers exposure to companies that benefit from the growing demand for cybersecurity products and solutions. This includes the securing of data, infrastructure and fighting against cybercrime.
FLWR is comprised of companies within the cannabis-derived pharmaceutical medicine, health and wellness solutions and agriculture technology industries.
Stuart Forbes (pictured), product lead and co-founder of Rize, commented: “The only way that you can legitimately capture the companies best exposed to an emerging theme for which traditional sector classifications are not available, is to partner with thematic research houses that have a unique ability to distil a theme into investable sub-classifications to identify the companies that are best exposed to the structural tailwinds of a theme using a bottom-up approach.
Sign up to ETF Stream’s weekly email here